Clinical Trials
3 trialsNCT01003769 2020-06-16
Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia
Mayo Clinic
Phase 1/2 Terminated
NCT01285635 2016-03-31
A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck
University of Michigan Rogel Cancer Center
Phase 2 Terminated
NCT00561197 2013-01-04
An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
Ascenta Therapeutics
Phase 1/2 Terminated